MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

国药准字H20243347

March 19, 2024

Drug Information

酒石酸溴莫尼定滴眼液

眼用制剂

0.2%(5ml:10mg)

化学药品

March 19, 2024

Company Information

Applicant Company

山东省枣庄市高新技术产业开发区神工路369号

Manufacturing Company

德州经济开发区晶华路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath